SiMPLI (Biotechnology) Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 1


  • Latest Deal Type
  • Debt

  • Investors
  • 1

SiMPLI (Biotechnology) General Information


Developer of in-vitro toxicology testing technology intended to provide a drop in replacement cell culture insert. The company's technology markets the next generation of consumable labware for the design of early-stage toxicity testing, enabling toxicologists and drug designers to understand their biological barriers, without impacting processes or protocols.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Rue Fritz-Oppliger 18
  • 2504 Biel
  • Switzerland
+41 078 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SiMPLI (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - General 01-Nov-2020 000.00 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 000.00 000.00 Completed Generating Revenue
To view SiMPLI (Biotechnology)’s complete valuation and funding history, request access »

SiMPLI (Biotechnology) Patents

SiMPLI (Biotechnology) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4317397-A1 Multi-well plate system for assessing cell layers Pending 02-Aug-2022 000000000 0
US-11572536-B2 Well inserts with brittle membranes Active 11-May-2015 000000000 00
US-20180127694-A1 Well inserts with brittle membranes Active 11-May-2015 000000000 0
EP-3294861-A1 Well inserts with brittle membranes Pending 11-May-2015 000000000
US-20230151312-A1 Well inserts with brittle membranes and method of manufacturing the same Pending 11-May-2015 C12M23/00
To view SiMPLI (Biotechnology)’s complete patent history, request access »

SiMPLI (Biotechnology) Executive Team (1)

Name Title Board Seat Contact Info
Silvia Angeloni Founder, Business Development Manager, Board Member & Chief Executive Officer
To view SiMPLI (Biotechnology)’s complete executive team members history, request access »

SiMPLI (Biotechnology) Board Members (2)

Name Representing Role Since
Christine Cornioley Self Board Member 000 0000
Eric Klasen Self Board Member 000 0000
To view SiMPLI (Biotechnology)’s complete board members history, request access »

SiMPLI (Biotechnology) Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SiMPLI (Biotechnology) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Venture Kick Accelerator/Incubator Minority 000 0000 000000 0
To view SiMPLI (Biotechnology)’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »